Corpus Intelligence LBO — WILMINGTON TREATMENT CENTER INC 2026-04-26 11:55 UTC
LBO — WILMINGTON TREATMENT CENTER INC
IRR: 18.6% | MOIC: 2.35x
🛡️ Public data only — no PHI permitted on this instance.
18.6%
IRR
2.35x
MOIC
$26.7M
Entry EV
$43.5M
Exit EV
$13.7M
Equity Invested

Sources & Uses

S&UTotal · $26.7M
ItemAmount%Distribution
Senior Debt$10.4M38.8%
Sub Debt$2.6M9.7%
Equity$13.7M51.5%
Enterprise Value$25.9M97.1%
Transaction Fees$0.8M2.9%
Total Uses$26.7M100.0%

Interpretation

INT

At 2.35x MOIC and 18.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.

Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.

Returns Waterfall

WFL
ComponentValue
Exit Ebitda$4.1M
Exit Ev$43.5M
Net Debt At Exit$11.2M
Equity At Exit$32.2M
Equity Invested$13.7M
Total Value Created$18.5M
Value From Growth$16.2M
Value From Multiple$1.3M
Value From Deleveraging$1.7M